INTRODUCTION
============

Pathologic fractures of the long bones occur in 17--43% of patients with bone metastasis from lung cancer or other solid tumors ([@B1]). This is a devastating skeletal complication of advanced malignancies, which occasionally occurs as the first manifestation of cancer. Accurate diagnosis of pathologic fractures in cancer patients is crucial because the appropriate treatment options could differ from those for traumatic fractures, thus affecting the quality of life during an extended survival period ([@B2]).

Although plain radiography is the primary screening technique for evaluating suspected pathologic fractures, conventional magnetic resonance imaging (MRI) is the most preferred modality as it demonstrates superior resolution in bone marrow lesion; gadolinium-based contrast media can be recommended in order to optimize the detection and characterization of bone marrow lesion ([@B3][@B4]). Nonetheless, diagnostic challenges remain, particularly in acute-stage fractures, which often show aggressive appearances on MRI that can hide underlying metastatic lesions.

Diffusion-weighed imaging (DWI) is a functional imaging technique that is based on differences in the Brownian motion of water molecules between tissues. Various studies have been published on the utility of DWI in the detection, characterization, and longitudinal evaluation of bone and soft tissue tumors ([@B5][@B6][@B7]). In previous studies, although fractures have been evaluated with DWI, the focus has mostly been on differentiating malignant from osteoporotic vertebral compression fractures through measurement of apparent diffusion coefficient (ADC) values ([@B8][@B9][@B10][@B11][@B12][@B13]). The usefulness of DWI in evaluating suspected pathologic fractures at extremities has not yet been elucidated. Furthermore, no published data within the scope of the authors\' knowledge, are available on how addition of DWI to conventional MRI contributes to diagnostic value. Therefore, our study aimed to assess the diagnostic value of combining DWI with conventional MRI in differentiating between pathologic and traumatic fractures at extremities from metastasis.

MATERIALS AND METHODS
=====================

Patients
--------

This study was approved by the Institutional Review Board of our hospital, which waived requirement for informed consent because of the retrospective nature of the study. From September 2013 to December 2016, a total of 131 patients who presented with suspected pathologic fracture at extremities on initial plain radiographs obtained in the emergency room or at an outpatient clinic were enrolled; they had subsequently undergone contrast-enhanced (CE) MRI with DWI. Excluded criteria were age ≤ 18 years or pathologic fractures due to primary bone tumors. Some patients were excluded because of the following: a possible fracture on initial plain radiographs that was not evident on MRI (n = 26); unavailable DWI (n = 3); incomplete or stress fracture on MRI (n = 1); image distortion due to motion artifact (n = 1); loss to follow-up (n = 2). Finally, 98 patients were analyzed ([Fig. 1](#F1){ref-type="fig"}). The final diagnosis of a pathologic fracture was made by pathologic confirmation (n = 59) or inspection of the fracture site during surgery (n = 8) and by clinical and imaging follow-up in patients who were not considered appropriate candidates for surgery owing to their general conditions or short life expectancy (n = 31). Of 98 subjects, 49 had pathologic and 49 had traumatic fractures; eighty-eight (89.8%) patients had an underlying primary malignancy, absence of which was confirmed after diagnostic imaging workup and follow-up examinations including chest and abdominopelvic CT and/or positron emission tomography-CT. [Table 1](#T1){ref-type="table"} shows a comparison of the demographic data, including underlying primary malignancies and fracture locations at extremities, between the groups. Most patients had a history of trauma in the spectrum of low-to-high-energy trauma. The mean interval between the onset of symptoms and MRI was 12.2 days (range, 0--149 days; median, 1 day).

Conventional and Diffusion-Weighted MRI
---------------------------------------

MRI was performed using different MRI scanners with dedicated coils. A 1.5T MAGNETOM Avanto (Siemens Healthineers, Erlangen, Germany) MRI scanner was used in 62 patients, and 3T MRI scanners were used in 36 patients: Achieva (Philips Healthcare, Best, The Netherlands) in 23, Ingenia (Philips Healthcare) in nine, and MAGNETOM Skyra (Siemens Healthineers) in four. Conventional MRI sequences obtained were as follows: non-enhanced MRI (NEMR) including axial, sagittal, or coronal T1-weighted imaging (T1WI), and axial, sagittal, or coronal T2-weighted imaging (T2WI) with/without fat-saturation, as well as CE fat-saturated T1-weighted imaging (CEFST1) for all three planes. Before intravenous contrast material injection, DWI was performed in the axial plane using a spin-echo, single-shot echo-planar imaging sequence. ADC maps were calculated from b = 0, 400, and 1400 images. Acquisition parameters were adapted to the anatomical regions under assessment. [Table 2](#T2){ref-type="table"} summarizes the detailed parameters for each MRI sequence.

Imaging Analysis
----------------

Before the image review, an independent reader (with 4 years of experience in musculoskeletal imaging) was asked to evaluate conventional MRI without clinical and pathologic findings. First, the presence/absence of a focal bone abnormality at the fracture site was determined. The maximum diameter of the focal bone abnormality was recorded with the number of focal bone lesions as single or multiple, when a lesion was present within any field-of-view (FOV) of the three planes. A focal bone abnormality was defined as an abnormal bone marrow signal lesion with discrete margin at and/or around a fracture site on T1WI and/or discrete enhancement on CEFST1. Second, the presence of an extra-osseous soft tissue component was determined. Third, the presence of bone marrow enhancement at the fracture margin was evaluated on one or both sides of the fracture margin. We differentiated imaging findings of bone marrow edema from the focal bone abnormality based on an ill-defined, moderately decreased signal intensity on T1WI without a discrete enhanced margin on CEFST1.

For the image review, three imaging sets were defined: DWI plus NEMR (DW set), NEMR plus CEFST1 (CE set), and DWI plus NEMR plus CEFST1 (combined set). To differentiate between pathologic and traumatic fractures, a qualitative analysis was performed for each imaging set using a 5-point scale as follows: grade 1, definite traumatic fracture; grade 2, probable traumatic fracture; grade 3, possible pathologic fracture; grade 4, probable pathologic fracture; and grade 5, definite pathologic fracture. Subsequently, the scores on the 5-point scale were regrouped into a 3-level confidence system, with 1 indicating the lowest confidence and 3 the highest confidence. When evaluating DW and combined sets, DW-MR images and ADC map were placed alongside and evaluated for the presence of a focal bone abnormality at or around the fracture site on conventional MRI with a high signal on DWI and impeded water diffusivity on ADC map; this approach was similar to the method used by Sung et al. ([@B10]).

Two reviewers (one with 3 and the other with 19 years of experience in musculoskeletal imaging), who were not involved in patient selection, participated in the examination process retrospectively and independently. Three review sessions using a crossover design were performed by the two reviewers. In each session, images were randomly assigned to two anonymous groups by the previously mentioned independent reader. For three review sessions, three different combinations were created by combining two of the 3 groups of image sets, that is, the DW, CE, and combined sets. During the first session, the DW and CE sets in each group were evaluated. The combined and DW sets during the second session, and the CE and combined sets during the third session were evaluated in the same manner ([Fig. 1](#F1){ref-type="fig"}). To reduce recall bias, each session was conducted 4 weeks apart. All pathologic results and clinical and imaging data were reviewed thoroughly by the independent reader after images were reviewed.

Statistical Analysis
--------------------

The sensitivity, specificity, and accuracy of three sets were calculated for differentiating between pathologic and traumatic fractures. Subgroup analyses according to the presence of focal bone abnormality and the number of bone lesions within FOV, absence of extra-osseous soft tissue component, and presence of bone enhancement at fracture margins on conventional MRI was performed for calculating the sensitivity, specificity, and accuracy for each subgroup. McNemar\'s test was used to analyze the differences in diagnostic performance among three image sets in all patients and subgroups. Inter-reviewer agreement was tested using weighted κ statistics. A κ value of 0.00--0.20 indicated slight agreement; 0.21--0.40, fair agreement; 0.41--0.60, moderate agreement; 0.61--0.80, good agreement; and 0.81--1.00, excellent agreement. Statistical significance was set at *p* value \< 0.05. Commercially available software (MedCalc 17.0; MedCalc Software, Mariakerke, Belgium, and SPSS 24.0; IBM Corp., Armonk, NY, USA) were used for statistical analyses.

RESULTS
=======

Conventional MRI Findings at Fracture Margins with Pathologic Correlation
-------------------------------------------------------------------------

MRI revealed focal bone abnormalities in 57 (58.2%) of the 98 patients; 46 pathologic and 11 traumatic fractures were observed in these patients. Three pathologic fractures without a focal bone abnormality identified by MRI had diffuse bone marrow signal changes (n = 2) and a hematoma at the fracture site (n = 1). Eleven traumatic fractures showing focal bone abnormalities were confirmed as "no tumor present" during surgery (n = 9) and by clinical and radiological follow-up (n = 2); three of these had pathologically confirmed hematopoietic marrow, intramedullary hematoma, and hematoma with fat necrosis. The median maximum diameter of the focal bone abnormalities was 5.8 cm (range, 0.5--22 cm) in pathologic fractures and 3.2 cm (range, 1--11.4 cm) in traumatic fractures. Among the 57 patients with focal bone abnormalities, single lesions were found in 25 (43.9%) patients (16 pathologic and nine traumatic fractures) and multiple lesions in 32 (56.1%) patients (30 pathologic and two traumatic fractures). Two traumatic cases had multiple metastases in the pelvic bones; however, femoral fractures were confirmed as traumatic after operation.

An extra-osseous soft tissue component was observed in 16 (16.3%) patients (15 pathologic and one traumatic fracture). The lesion of one traumatic fracture was confirmed as non-union with granulation tissue.

Bone enhancement at fracture margins was present in 90 (91.8%) patients; 49 (100%) pathologic and 41(83.7%) traumatic fractures were observed in these patients ([Table 3](#T3){ref-type="table"}).

Diagnostic Performance for Differentiation between Pathologic and Traumatic Fractures
-------------------------------------------------------------------------------------

[Table 4](#T4){ref-type="table"} lists the sensitivity, specificity, and accuracy for the diagnosis of pathologic fracture at extremities in the DW, CE, and combined sets using 5-point scale, for each reader.

Diagnostic accuracy was the highest for combined set for both readers (reader 1 and 2, 95.9%). For reader 1, compared to the CE set, the combined set showed significantly improved diagnostic accuracy (84.7% vs. 95.9%, *p* \< 0.005) and specificity (71.4% vs. 93.9%, *p* \< 0.005). For reader 2, accuracy was increased significantly in the combined set compared to the CE set (91.8% vs. 95.9%, *p* = 0.04), with a trend of improving specificity (85.7% vs. 98%, *p* = 0.07). Sensitivity was not significantly different between the combined and CE sets for any reader (both, *p* \> 0.05). [Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"} show representative cases.

The diagnostic performance was not significantly different between the DW and CE sets and between the DW and combined sets for both readers (*p* \> 0.05).

Diagnostic Performance in Subgroup Analysis according to Conventional MRI Findings
----------------------------------------------------------------------------------

For reader 1, CE set showed accuracy (76.0--84.4%) and moderate specificity (44.4--72.9%) in cases of a single bone abnormality, absent extra-osseous soft tissue component, and present bone enhancement at fracture margins. However, compared to the CE set, the combined set showed significantly improved accuracy (82.9% vs. 96.3%, 84.4% vs. 95.6%, *p* \< 0.05) and specificity (72.9% vs. 95.8%, 68.3% vs. 92.7%, *p* \< 0.005) in cases of absent extra-osseous soft tissue component and present bone enhancement at fracture margins.

For reader 2, in cases of absent extra-osseous soft tissue component and present bone enhancement at fracture margins, accuracy was significantly increased in the combined set compared with that in the CE set (90.2% vs. 95.1%, 91.1% vs. 95.6%, *p* \< 0.05) with a trend of improvement in specificity (85.4% vs. 98.0%, 83.0% vs. 97.6%, *p* = 0.07).

Compared to the CE set, the combined set also showed improved accuracy (R1, 76% vs. 92.0%; R2, 88.0% vs. 100%) and specificity (R1, 44.4% vs. 77.8%; R2, 77.8% vs. 100%) in cases of a single bone abnormality, but without a significant difference (*p* \> 0.05) ([Table 4](#T4){ref-type="table"}).

The diagnostic performance was not significantly different between the DW and CE sets and between the DW and combined sets for both readers (*p* \> 0.05) ([Table 4](#T4){ref-type="table"}).

Observer Reproducibility and Diagnostic Confidence
--------------------------------------------------

Compared to the CE set, the combined set showed excellent inter-reader agreement, with a weighted κ value of 0.830 (95% confidence interval \[CI\]: 0.760--0.901). Inter-reader agreement was good in the CE and DW sets, with weighted κ values of 0.665 (95% CI: 0.574--0.757) and 0.675 (95% CI: 0.577--0.773), respectively. For both readers, the mean diagnostic confidence increased in the combined set compared to the CE set for traumatic fractures (R1, 2.66--2.84; R2, 2.65--2.72).

DISCUSSION
==========

Our results showed that compared to the CE set, the combined set showed improved accuracy and specificity for diagnosis of pathologic fractures at extremities, while retaining sensitivity. This indicates the role of DWI when combined with conventional MRI: equivocal MRI findings in elderly patients who are likely to have underlying malignancy might lead to a false-positive diagnosis. Such incorrect diagnoses in the CE set could be corrected by confirming the absence of tumor using DWI and ADC, which was consistent with results in the previous studies ([@B5][@B14][@B15]). These results could be advantageous for appropriately managing patients at risk by eliminating, or at least reducing, the false-positive diagnoses of pathologic fractures. This explanation also supports the improved confidence level in the traumatic fracture group after adding DWI.

We evaluated the ADC map qualitatively; however, its diagnostic performance in our study was similar to that in previous studies (sensitivity, 81--100%; specificity, 78.9--97%) ([@B10][@B16]). Absolute ADC values can be affected by many factors, such as scanner parameters and vendorspecific issues, including field inhomogeneity, coils, eddy currents, and sequence designs ([@B17][@B18]). ADC value measurement involves additional confounding factors, such as region of interest (ROI) positioning, because the size and location of an ROI is decisive in ADC quantitative analysis, which necessitates avoiding artifacts, partial volume effects, and areas of hemorrhage and necrosis. Investigations regarding optimal positioning are ongoing despite reports on comparisons among different methods of ROI positioning ([@B19][@B20]). We speculated that correlating the presumed solid portions on conventional MRI with DWI and ADC can provide sufficient guidance, leading to enhanced diagnostic accuracy without measuring ADCs. Pathologic fractures at extremities may demonstrate complex appearances, with hemorrhage, bone marrow of the fractured fragments, and intermingled adjacent soft tissue changes. Such situations can cause further challenges in accurate ROI positioning for representing the solid portion rather than vertebral compression fractures.

With conventional MRI, morphologic evaluation of pathologic fractures in cancer patients are based on the presence of focal bone abnormalities, indicating a tumor, extra-osseous soft tissue mass, or irregular areas of marked and inhomogeneous contrast enhancement of fractured bones ([@B3]). Multiple lesions can also suggest the presence of metastasis. In this study, we focused on the complicated situations that impede confident diagnoses of metastatic pathologic fractures in the clinical setting; for this purpose, we performed subgroup analyses excluding cases of multiple bone lesions, existing extra-osseous soft tissue component, or absent bone enhancement at fracture margins. In our study, pathologic fracture without an extra-osseous soft tissue mass was observed in up to 69.4% (34/49). Moreover, traumatic fracture showing bone enhancement at fracture margins was observed over 80% patients, although they had varying enhancement degrees. Bone marrow at the acute traumatic fracture site becomes edematous or is replaced by intramedullary hematomas and then shows a hyperemic response, thus altering the marrow relaxation time and showing fracture site enhancement ([@B4][@B8][@B11]). In our study, the additional use of DWI with conventional MRI demonstrated improved accuracy and specificity, particularly for the less-experienced reader, in cases of absent extra-osseous soft tissue mass and present bone enhancement, i.e., the situations that may make accurate interpretation more challenging on conventional MRI.

In this study, in cases of single bone abnormality, the combined set showed a trend of improvement in accuracy and specificity for reader 1, and up to 100% sensitivity, specificity and accuracy for reader 2, although the difference was not statistically significant. When a single bone abnormality is found in a patient who has a suspected pathologic fracture, it is not easy to distinguish benign from malignant causes, particularly when the size of a focal bone lesion is small without associated findings on MRI. Moreover, the presence of single-bone metastasis is considerably important as it may affect tumor stage in cancer patients. In such cases of our study, excluding the false-positive cases by demonstrating no impeded water diffusivity on DWI and ADC map could increase the specificity, and eventually increase the accuracy. Notably, there was a false positive case where DWI did not aid in establishing a correct diagnosis. Pathologically proven focal hematopoietic marrow in the femur which showed subtle high signal change on DWI and low signal intensity on ADC map was misdiagnosed as metastasis by reader 1. This well-known misleading focus on DWI and ADC map emphasizes the importance of fundamental analysis of morphologic features on conventional MRI.

CE imaging has become a key component of conventional MRI to discriminate underlying normal bone marrow from tumor involvement for assessing malignant pathologic fracture. However, moderate specificity of the CE set was observed in our study, and this was consistent with results of the previous studies, which reported limited specificity (71% and 70%) of CE images in diagnosing vertebral compression fractures ([@B12][@B13]). In our study, when comparisons were made between the CE and DW sets and between the DW and combined sets, the diagnostic performance did not differ significantly. Therefore, our results suggest that DWI could be an alternative imaging sequence to CE imaging for evaluating pathologic fractures in patients with impaired renal function or unstable conditions.

Our study has some limitations. First, it was a retrospective study with relatively small number of patients. Nonetheless, the cause of fractures was confirmed by biopsy or operation in more than 50% of patients. Furthermore, any study did not investigate whether and how the addition of DWI to conventional MRI improved diagnostic performance for differentiating pathologic and traumatic fractures at extremities. Second, we did not measure ADC values but instead focused on visual analysis, and thus, we could not propose cut-off reference values for differentiation. Drawing an ROI on a lesion could be confounded by many factors including limited reproducibility in quantitative analysis ([@B21][@B22]), however, we believe that such qualitative analysis is preferable in clinical practice, particularly for evaluating pathologic fractures at extremities where often heterogeneous and complicated findings are observed. Third, in analyzing bone enhancement at fracture margins on conventional MRI, we did not evaluate the enhancement patterns and degrees, as enhancement might have varied at fractures over time. Time to healing is also variable, especially in elderly with potentially impeded reparative capacity. Fourth, we included patients with different kinds of primary cancers. Signal intensity of bone metastasis on DWI and ADC map may be different depending on cancer types, although no significant associations between ADC values and types of primary cancer were found for bone metastasis ([@B23]). Fifth, we included both myeloma and lymphoma cases. However, orthopedic management of their pathologic fractures is closely related to the treatment of the metastatic lesions.

In conclusion, combining DWI with conventional MRI improved diagnostic accuracy and specificity while retaining sensitivity in the evaluation of suspected pathologic fractures from metastasis at extremities, even in cases of absent extra-osseous soft tissue mass and present bone enhancement at fracture margins, which may make interpretation more challenging with conventional MRI, especially for less-experienced radiologists. DWI could be a useful supplement to routine MRI protocols for differentiating between pathologic and traumatic fractures at extremities from metastasis.
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![Study flowchart.\
CE = contrast-enhanced, CE set = NEMR plus CE fat-saturated T1-weighted imaging, Combined set = DWI plus CE set, DWI = diffusion-weighted imaging, DW set = DWI plus NEMR, MRI = magnetic resonance imaging, NEMR = non-enhanced MRI](kjr-20-812-g001){#F1}

![CE and combined sets demonstrate correct diagnosis of pathologic fracture by both readers at left femur in 55-year-old woman with multiple myeloma.\
**(A)** Axial T1-weighted, and **(B)** axial contrast-enhanced fat-saturated T1-weighted images show intramedullary enhancing single bone abnormality at fracture site with perilesional edema (asterisks). **(C)** Corresponding axial DWI shows high signal change at fracture site (b = 1400 s/mm^2^). **(D)** Axial ADC map shows impeded water diffusivity. ADC = apparent diffusion coefficients](kjr-20-812-g002){#F2}

![CE and combined sets demonstrate discordant interpretations of traumatic fracture at left femur in 56-year-old woman with vaginal cancer.\
Initial diagnosis of reader 1 from CE set was pathologic fracture due to focal bone abnormality on T1-weighted images with enhancement at fracture margin, in which DWI is added to CE set, reader 1 changed diagnosis to traumatic fracture. **(A)** Coronal T1-weighted and **(B)** axial contrast enhanced fat-saturated T1-weighted images show single bone abnormality with bone marrow enhancement at fracture site in left proximal femur, neck (arrows). **(C)** Corresponding axial DWI shows no high signal at fracture site (b = 1400 s/mm^2^). **(D)** Axial ADC map shows no impeded water diffusivity. This case was pathologically confirmed as intramedullary hemorrhage with traumatic fracture.](kjr-20-812-g003){#F3}

###### Characteristics of Study Population

![](kjr-20-812-i001)

  Patients Included (n = 98)               Patients with Pathologic Fractures (n = 49)   Patients with Traumatic Fractures (n = 49)
  ---------------------------------------- --------------------------------------------- --------------------------------------------
  Age (years ± SD)                         64 ± 12                                       66 ± 14
  Sex (male/female)                        19/30                                         21/29
  Underlying primary malignancy (n = 88)                                                 
   Lung cancer                             13                                            8
   Hepatocellular carcinoma                9                                             3
   Breast cancer                           5                                             4
   Colorectal cancer                       4                                             5
   Advanced gastric cancer                 0                                             3
   Cholangiocarcinoma                      3                                             0
   Prostate cancer                         3                                             1
   Renal cell carcinoma                    1                                             2
   Cervical cancer                         1                                             1
   Thyroid cancer                          1                                             3
   Others^\*^                              9                                             9
  Absent primary malignancy (n = 10)       0                                             10
  Fracture location (n = 98)                                                             
   Femur                                   33                                            41
   Humerus                                 14                                            5
   Others^†^                               2                                             3

^\*^Involved combined hepatocellular-cholangiocarcinoma (n = 1), sinonasal undifferentiated carcinoma in nasal cavity (n = 1), gastrointestinal stromal tumor (n = 2), undifferentiated pleomorphic sarcoma (n = 1), esophageal cancer (n = 1), vaginal cancer (n = 1), multiple myeloma (n = 4), lymphoma (n = 1), pancreatic cancer (n = 2), ovary cancer (n = 1), leiomyosarcoma (n = 1), primitive neuroectodermal tumor (n = 1), ^†^Involved clavicle (n = 2), tibia (n = 2), scapula (n = 1). SD = standard deviation

###### MRI Sequence Parameters

![](kjr-20-812-i002)

  Parameters                                                   Standard Imaging                                           DWI
  ------------------------------------------------------------ ---------------------------------------------------------- -------------------
  Repetition time (ms)/echo time (ms)                          T1-weighted coronal or sagittal imaging: 456--587/12--20   5000--5200/61--85
  T2-weighted coronal or sagittal imaging: 2291--2978/60--80                                                              
  T1-weighted axial imaging: 475--588/15                                                                                  
  T2-weighted axial imaging: 2291--2696/80                                                                                
  Fat suppression                                              SPAIR                                                      SPAIR
  Echoplanar imaging factor                                    NA                                                         67
  Matrix                                                       325 x 257--448 x 250                                       184 x 256
  Field of view (mm)                                           Sagital imaging: 100--400                                  179--380
  Axial imaging: 80--399                                                                                                  
  Coronal imaging: 198--449                                                                                               
  Section thickness (mm)                                       1--3                                                       2.5--5
  Intersection gap (mm)                                        0--0.05                                                    0--1
  Turbo factor                                                 T1-weighted imaging: 3                                     NA
  T2-weighted imaging: 16                                                                                                 
  Number of signals acquired                                   2--4                                                       2--6

DWI = diffusion-weighted imaging, MRI = magnetic resonance imaging, NA = not applicable, SPAIR = spectral attenuated inversion recovery

###### Analysis Results of Conventional MRI Findings at Fracture Margins

![](kjr-20-812-i003)

  Imaging Findings                      Pathologic Fractures (n = 49)   Traumatic Fractures (n = 49)   Total (n = 98)
  ------------------------------------- ------------------------------- ------------------------------ ----------------
  Focal bone abnormality                                                                               
   Presence (single/multiple)           46 (16/30)                      11 (9/2)                       57 (25/32)
   Absence                              3                               38                             41
  Extra-osseous soft tissue component                                                                  
   Presence                             15                              1                              16
   Absence                              34                              48                             82
  Fracture site enhancement                                                                            
   Presence                             49                              41                             90
   Absence                              0                               8                              8

###### Diagnostic Performance in Overall and Subgroup Analysis for Evaluating Pathologic Fractures in Two Readers Using 5-Point Scale

![](kjr-20-812-i004)

                                                        CE set (%)   DW set (%)   Combined set (%)   *P*           
  ----------------------------------------------------- ------------ ------------ ------------------ ------ ------ -----------
  Overall (n = 98)                                                                                                 
   Reader 1                                                                                                        
    Sensitivity                                         98.0         93.9         98.0               0.63   0.50   1.0
    Specificity                                         71.4         81.6         93.9               0.36   0.07   0.001^\*^
    Accuracy                                            84.7         87.8         95.9               0.21   0.34   0.003^\*^
   Reader 2                                                                                                        
    Sensitivity                                         98.0         95.9         94.9               1.00   1.00   0.63
    Specificity                                         85.7         89.8         98.0               0.73   0.13   0.07
    Accuracy                                            91.8         92.9         95.9               0.55   0.13   0.04^\*^
  Single bone abnormality (n = 25)                                                                                 
   Reader 1                                                                                                        
    Sensitivity                                         93.7         93.8         100.0              1.00   1.00   1.0
    Specificity                                         44.4         77.8         77.8               0.38   1.00   0.25
    Accuracy                                            76.0         88.0         92.0               0.45   1.00   0.63
   Reader 2                                                                                                        
    Sensitivity                                         93.8         93.8         100.0              1.00   1.00   1.0
    Specificity                                         77.8         88.9         100.0              1.00   1.00   0.5
    Accuracy                                            88.0         92.0         100.0              1.00   1.00   1.0
  Absent extra-osseous soft tissue component (n = 82)                                                              
   Reader 1                                                                                                        
    Sensitivity                                         97.1         91.2         97.1               0.63   0.50   1.0
    Specificity                                         72.9         83.3         95.8               0.36   0.07   0.001^\*^
    Accuracy                                            82.9         86.6         96.3               0.21   0.34   0.003^\*^
   Reader 2                                                                                                        
    Sensitivity                                         97.1         94.1         91.2               1.00   1.00   0.63
    Specificity                                         85.4         89.6         98.0               0.73   0.13   0.07
    Accuracy                                            90.2         91.5         95.1               0.55   0.13   0.039^\*^
  Present fracture site enhancement (n = 90)                                                                       
   Reader 1                                                                                                        
    Sensitivity                                         98.0         93.9         98.0               0.63   0.50   1.0
    Specificity                                         68.3         80.5         92.7               0.33   0.13   0.002^\*^
    Accuracy                                            84.4         87.8         95.6               0.19   0.51   0.006^\*^
   Reader 2                                                                                                        
    Sensitivity                                         98.0         95.9         93.9               1.00   1.00   0.63
    Specificity                                         83.0         90.2         97.6               0.45   0.25   0.07
    Accuracy                                            91.1         93.3         95.6               0.34   0.22   0.04^\*^

^\*^Indicated significant difference between two groups. CEFST1 = contrast-enhanced fat-saturated T1-weighted imaging, CE set = NEMR plus CEFST1, Combined set = DWI plus NEMR plus CEFST1, DW set = DWI plus NEMR, NEMR = non-enhanced MRI
